Accendra Health
221 hedge funds and large institutions have $1.04B invested in Accendra Health in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 72 increasing their positions, 74 reducing their positions, and 44 closing their positions.
374% more call options, than puts
Call options by funds: $3.15M | Put options by funds: $665K
0.63% less ownership
Funds ownership: 101.63% → 101% (-0.63%)
3% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 74
4% less funds holding
Funds holding: 231 → 221 (-10)
16% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 44
52% less capital invested
Capital invested by funds: $2.15B → $1.04B (-$1.11B)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$30.6M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$8.64M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$4.27M |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$4.26M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIP
Epoch Investment Partners
New York
|
-$14.7M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$11.8M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$11.5M |
| 4 |
BlackRock
New York
|
-$10.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.8M |
ACH Hedge Fund Activity: Q2 2024 in Review
221 of the 6,931 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q2 2024, worth a combined $1.04B — down 52% from $2.15B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of ACH and 37 opened new positions — a net loss of 7 holders — while 74 trimmed existing stakes and 72 added.
The largest buyer was Deerfield Management, adding an estimated $30.6M. The largest seller was Epoch Investment Partners, exiting entirely with an estimated $14.7M sold.
- 221 institutional investors held Accendra Health (ACH) as of Q2 2024, down from 231 in Q1 2024.
- Funds reported $1.04B of Accendra Health stock for Q2 2024, down 52% quarter-over-quarter.
- 37 funds opened new Accendra Health positions in Q2 2024 and 44 closed out, a net change of -7 holders.
- The largest Accendra Health buyer in Q2 2024 was Deerfield Management, an estimated $30.6M added.
- The largest Accendra Health seller in Q2 2024 was Epoch Investment Partners, an estimated $14.7M sold.
Based on aggregated 13F filings for Q2 2024.